172 related articles for article (PubMed ID: 18797063)
1. Hodgkin's lymphoma in a patient of psoriasis treated with long-term, low-dose methotrexate therapy.
Khopkar U; Bhor U
Indian J Dermatol Venereol Leprol; 2008; 74(4):379-82. PubMed ID: 18797063
[TBL] [Abstract][Full Text] [Related]
2. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
Kumar B; Saraswat A; Kaur I
Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
[TBL] [Abstract][Full Text] [Related]
3. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
Dogra S; Krishna V; Kanwar AJ
Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
[TBL] [Abstract][Full Text] [Related]
5. [Early onset of methotrexate-associated lymphoproliferative disorder mimicking Hodgkin's lymphoma].
Burg MR; Schneider SW
Hautarzt; 2022 Jan; 73(1):71-74. PubMed ID: 33796880
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate.
Padeh S; Sharon N; Schiby G; Rechavi G; Passwell JH
J Rheumatol; 1997 Oct; 24(10):2035-7. PubMed ID: 9330950
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
[TBL] [Abstract][Full Text] [Related]
10. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
van Dooren-Greebe RJ; Kuijpers AL; Termorshuizen F; van de Kerkhof PC
Acta Derm Venereol; 1995 Sep; 75(5):393-6. PubMed ID: 8615062
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
Yesudian PD; Leman J; Balasubramaniam P; Macfarlane AW; Al-Niaimi F; Griffiths CE; Burden AD; Warren RB
J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
[TBL] [Abstract][Full Text] [Related]
12. Reversible Epstein-Barr virus-negative lymphadenopathy and bone marrow involved by Hodgkin's lymphoma in a rheumatoid arthritis patient undergoing long-term treatment with low-dose methotrexate: a case report and review of the literature.
Svensson AM; Jacobson ER; Ospina D; Tindle BH
Int J Hematol; 2006 Jan; 83(1):47-50. PubMed ID: 16443552
[TBL] [Abstract][Full Text] [Related]
13. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
Radmanesh M; Rafiei B; Moosavi ZB; Sina N
Int J Dermatol; 2011 Oct; 50(10):1291-3. PubMed ID: 21950300
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab for Methotrexate-associated Classic Hodgkin's Lymphoma in a Rheumatoid Arthritis Patient.
Tanaka K; Kuboki M; Koi S; Toyota S
Intern Med; 2020 Mar; 59(6):829-833. PubMed ID: 31761888
[TBL] [Abstract][Full Text] [Related]
15. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
[TBL] [Abstract][Full Text] [Related]
16. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
Thomas JA; Aithal GP
Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-betamethasone weekly oral pulse in psoriasis.
Gupta R; Gupta S
J Dermatolog Treat; 2007; 18(5):291-4. PubMed ID: 17852636
[TBL] [Abstract][Full Text] [Related]
18. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
[TBL] [Abstract][Full Text] [Related]
20. Multiple toxic effects of low-dose methotrexate in a patient treated for psoriasis.
Bookstaver PB; Norris L; Rudisill C; DeWitt T; Aziz S; Fant J
Am J Health Syst Pharm; 2008 Nov; 65(22):2117-21. PubMed ID: 18997139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
